FLI-06 2 mg | Purity Not Available
TargetMol
FLI-06
Search Results
FLI-06 25 mg | Purity Not Available
TargetMol
FLI-06
FLI-06 10 mg | Purity Not Available
TargetMol
FLI-06
GLPG0634 analog 5 mg | 99.22%
TargetMol
GLPG0634 (analog) is a specific JAK1 inhibitor with IC50 of 10/28/810/116 nM for JAK1/2/3 and TYK2, respectively.
More Information Supplier PageGLPG0634 analog
6-Thioguanine 100 mg | 98.75%
TargetMol
Thioguanine is an antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.
More Information Supplier Page6-Thioguanine
SMER28 100 mg | 99.97%
TargetMol
SMER28 is a small-molecule enhancer (SMER) of autophagy, inducing autophagy independently of rapamycin in mammalian cells via an mTOR-independent mechanism and prevented the accumulation of amyloid beta peptide.
More Information Supplier PageSMER28
JNJ-42041935 5 mg | 98.00%
TargetMol
JNJ-42041935 (HIF-PHD Inhibitor II) is a potent (pKi = 7.3-7.9), 2-oxoglutarate competitive, reversible, and selective inhibitor of PHD enzymes.
More Information Supplier PageJNJ-42041935
JNJ-42041935 10 mg | 98.00%
TargetMol
JNJ-42041935 (HIF-PHD Inhibitor II) is a potent (pKi = 7.3-7.9), 2-oxoglutarate competitive, reversible, and selective inhibitor of PHD enzymes.
More Information Supplier PageJNJ-42041935
SMER28 5 mg | 99.97%
TargetMol
SMER28 is a small-molecule enhancer (SMER) of autophagy, inducing autophagy independently of rapamycin in mammalian cells via an mTOR-independent mechanism and prevented the accumulation of amyloid beta peptide.
More Information Supplier PageSMER28
SMER28 50 mg | 99.97%
TargetMol
SMER28 is a small-molecule enhancer (SMER) of autophagy, inducing autophagy independently of rapamycin in mammalian cells via an mTOR-independent mechanism and prevented the accumulation of amyloid beta peptide.
More Information Supplier PageSMER28